JP5465815B2 - 関節症治療剤 - Google Patents

関節症治療剤 Download PDF

Info

Publication number
JP5465815B2
JP5465815B2 JP2013542900A JP2013542900A JP5465815B2 JP 5465815 B2 JP5465815 B2 JP 5465815B2 JP 2013542900 A JP2013542900 A JP 2013542900A JP 2013542900 A JP2013542900 A JP 2013542900A JP 5465815 B2 JP5465815 B2 JP 5465815B2
Authority
JP
Japan
Prior art keywords
group
phosphatidic acid
formula
arthropathy
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013542900A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2013069404A1 (ja
Inventor
きみ子 室伏
郁子 益田
俊郎 諸星
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho
Original Assignee
Sansho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho filed Critical Sansho
Priority to JP2013542900A priority Critical patent/JP5465815B2/ja
Application granted granted Critical
Publication of JP5465815B2 publication Critical patent/JP5465815B2/ja
Publication of JPWO2013069404A1 publication Critical patent/JPWO2013069404A1/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2013542900A 2011-11-11 2012-10-12 関節症治療剤 Active JP5465815B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013542900A JP5465815B2 (ja) 2011-11-11 2012-10-12 関節症治療剤

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2011247047 2011-11-11
JP2011247047 2011-11-11
PCT/JP2012/076478 WO2013069404A1 (ja) 2011-11-11 2012-10-12 関節症治療剤
JP2013542900A JP5465815B2 (ja) 2011-11-11 2012-10-12 関節症治療剤

Publications (2)

Publication Number Publication Date
JP5465815B2 true JP5465815B2 (ja) 2014-04-09
JPWO2013069404A1 JPWO2013069404A1 (ja) 2015-04-02

Family

ID=48289788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013542900A Active JP5465815B2 (ja) 2011-11-11 2012-10-12 関節症治療剤

Country Status (15)

Country Link
US (1) US9085593B2 (enExample)
EP (1) EP2803359B1 (enExample)
JP (1) JP5465815B2 (enExample)
KR (1) KR101953181B1 (enExample)
CN (1) CN103906519B (enExample)
AU (1) AU2012337087B2 (enExample)
BR (1) BR112014011315B8 (enExample)
CA (1) CA2855660C (enExample)
ES (1) ES2634008T3 (enExample)
IN (1) IN2014CN04222A (enExample)
MY (1) MY168931A (enExample)
PH (1) PH12014501058B1 (enExample)
RU (1) RU2646457C2 (enExample)
SG (1) SG11201402226PA (enExample)
WO (1) WO2013069404A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022114058A1 (ja) 2020-11-26 2022-06-02 Sansho株式会社 肺線維症治療剤

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3483169B1 (en) 2014-08-12 2021-05-26 Otsuka Chemical Co., Ltd. Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same
JP6727596B1 (ja) 2019-11-22 2020-07-22 国立大学法人お茶の水女子大学 カルバリゾホスファチジン酸
TWI868287B (zh) 2019-12-23 2025-01-01 日商大塚化學股份有限公司 carba-環狀磷脂酸化合物
JP7736256B2 (ja) * 2020-11-13 2025-09-09 株式会社マツモト交商 環状ホスファチジン酸含有組成物及び美容方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07149772A (ja) * 1993-11-26 1995-06-13 Sagami Chem Res Center タンパク質リン酸化酵素cの活性促進剤
JP2004010582A (ja) * 2002-06-11 2004-01-15 Gencom Co カルバ環状ホスファチジン酸誘導体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2700350B2 (ja) 1990-04-20 1998-01-21 小糸工業株式会社 車両感知器
JP3195833B2 (ja) 1991-09-30 2001-08-06 きみ子 室伏 新規生理活性物質及びその製造法
JPH07258278A (ja) 1994-03-18 1995-10-09 Sagami Chem Res Center 1−O−アシルグリセロール−2,3−ホスフェート誘導体を有効成分とするDNAポリメラーゼαの阻害剤
JPH0925235A (ja) 1995-07-13 1997-01-28 Sagami Chem Res Center 1−o−アシルグリセロール−2,3−ホスフェート誘導体を有効成分とするがん転移抑制剤
JP2001178489A (ja) 1999-12-24 2001-07-03 Kimiko Murofushi 環状ホスファチジン酸の製造法
JP4836345B2 (ja) * 2001-04-13 2011-12-14 きみ子 室伏 環状ホスファチジン酸誘導体を含む神経細胞の生存促進剤
JP4815063B2 (ja) * 2001-04-13 2011-11-16 きみ子 室伏 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び/又は生存の促進のための薬剤
US20040214799A1 (en) * 2001-05-21 2004-10-28 Mutsuko Mukai Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives
RU2240131C1 (ru) * 2003-04-04 2004-11-20 Аладьев Сергей Иванович Средство "артровит" для профилактики и лечения артритов и артрозов
EP1613298A4 (en) * 2003-04-11 2007-10-03 Univ Tennessee Res Foundation Lysophosphatidic Acid Analysis and Inhibition of Neointimal Formation
CN101163692B (zh) 2005-02-16 2012-01-18 先灵公司 具有cxcr3拮抗活性的杂环取代的哌嗪
KR20090097943A (ko) * 2006-12-28 2009-09-16 오짜노미즈 유니버시티 환상 포스파티딘산 유도체를 포함하는 진통제
JP2010189315A (ja) * 2009-02-18 2010-09-02 Unitika Ltd 関節軟骨損傷治癒促進剤及びそれを含有する飲食品

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07149772A (ja) * 1993-11-26 1995-06-13 Sagami Chem Res Center タンパク質リン酸化酵素cの活性促進剤
JP2004010582A (ja) * 2002-06-11 2004-01-15 Gencom Co カルバ環状ホスファチジン酸誘導体

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022114058A1 (ja) 2020-11-26 2022-06-02 Sansho株式会社 肺線維症治療剤

Also Published As

Publication number Publication date
ES2634008T3 (es) 2017-09-26
IN2014CN04222A (enExample) 2015-07-17
EP2803359A1 (en) 2014-11-19
CN103906519B (zh) 2017-10-10
JPWO2013069404A1 (ja) 2015-04-02
HK1199406A1 (en) 2015-07-03
RU2014123690A (ru) 2015-12-20
EP2803359A4 (en) 2015-12-16
WO2013069404A1 (ja) 2013-05-16
PH12014501058B1 (en) 2019-11-08
BR112014011315B8 (pt) 2020-09-15
CA2855660A1 (en) 2013-05-16
RU2646457C2 (ru) 2018-03-05
NZ624870A (en) 2016-01-29
BR112014011315A2 (pt) 2017-05-09
EP2803359B1 (en) 2017-04-19
SG11201402226PA (en) 2014-10-30
MY168931A (en) 2019-01-09
US20140309194A1 (en) 2014-10-16
AU2012337087A1 (en) 2014-06-05
KR101953181B1 (ko) 2019-02-28
CN103906519A (zh) 2014-07-02
US9085593B2 (en) 2015-07-21
PH12014501058A1 (en) 2014-06-23
KR20140098778A (ko) 2014-08-08
AU2012337087B2 (en) 2016-11-17
BR112014011315B1 (pt) 2020-03-03
CA2855660C (en) 2019-04-16

Similar Documents

Publication Publication Date Title
JPWO2013069404A1 (ja) 関節症治療剤
EP1402894B1 (en) Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives
US8017597B2 (en) Analgesic agent comprising cyclic phosphatidic acid derivative
WO2022234855A1 (ja) 中枢毒性が低減したオリゴヌクレオチドの設計方法
EP3697412B1 (en) A compound for treating osteoarthritis
EP4049724A1 (en) Pharmaceutical composition for protecting cartilage
JP6864899B2 (ja) 損傷治療剤
JP5747263B2 (ja) 神経細胞死抑制剤
HK1199406B (en) Therapeutic agent for joint diseases
KR20060028630A (ko) 이노시톨 폴리포스페이트 유도체 및 그의 사용 방법
JPH09227386A (ja) ストレス蛋白質発現増強剤
NZ624870B2 (en) Therapeutic agent for arthrosis
WO2022114058A1 (ja) 肺線維症治療剤
KR20000048499A (ko) 이노시톨 폴리포스페이트 유도체 및 그의 사용 방법
JP2001064168A (ja) 変形性関節症治療剤

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140114

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140122

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5465815

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313114

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250